Acumen Pharmaceuticals, Inc. (ABOS)
1.78
+0.09
(+5.33%)
USD |
NASDAQ |
Oct 19, 16:00
1.78
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Market Cap : 128.72M for Oct. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 122.21M |
| October 15, 2026 | 120.77M |
| October 14, 2026 | 126.19M |
| October 13, 2026 | 131.25M |
| October 12, 2026 | 146.08M |
| October 09, 2026 | 154.75M |
| October 08, 2026 | 151.86M |
| October 07, 2026 | 151.86M |
| October 06, 2026 | 146.80M |
| October 05, 2026 | 154.03M |
| October 02, 2026 | 147.52M |
| October 01, 2026 | 149.69M |
| September 30, 2026 | 160.54M |
| September 29, 2026 | 162.35M |
| September 28, 2026 | 166.32M |
| September 25, 2026 | 161.98M |
| September 24, 2026 | 161.62M |
| September 23, 2026 | 166.69M |
| September 22, 2026 | 191.63M |
| September 21, 2026 | 187.30M |
| September 18, 2026 | 191.63M |
| September 17, 2026 | 185.85M |
| September 16, 2026 | 188.74M |
| September 15, 2026 | 208.99M |
| September 14, 2026 | 201.76M |
| Date | Value |
|---|---|
| September 11, 2026 | 211.16M |
| September 10, 2026 | 206.82M |
| September 09, 2026 | 206.10M |
| September 08, 2026 | 228.51M |
| September 04, 2026 | 229.96M |
| September 03, 2026 | 223.45M |
| September 02, 2026 | 224.18M |
| September 01, 2026 | 211.16M |
| August 31, 2026 | 206.10M |
| August 28, 2026 | 211.16M |
| August 27, 2026 | 219.11M |
| August 26, 2026 | 216.22M |
| August 25, 2026 | 224.18M |
| August 24, 2026 | 222.37M |
| August 21, 2026 | 228.51M |
| August 20, 2026 | 230.68M |
| August 19, 2026 | 227.79M |
| August 18, 2026 | 198.14M |
| August 17, 2026 | 192.36M |
| August 14, 2026 | 193.08M |
| August 13, 2026 | 184.40M |
| August 12, 2026 | 181.51M |
| August 11, 2026 | 178.62M |
| August 10, 2026 | 175.72M |
| August 07, 2026 | 176.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 34.49B |
| ACADIA Pharmaceuticals, Inc. | 3.410B |
| Alnylam Pharmaceuticals, Inc. | 31.21B |
| Anika Therapeutics, Inc. | 270.87M |
| Savara, Inc. | 952.03M |
Market Cap Related Metrics
| Price to Book Value | 2.248 |
| Price | 1.78 |
| Earnings Yield | -91.71% |